![](/images/general/no_picture/200_user.png)
Sharmistha N Gupta
Examiner (ID: 16074)
Most Active Art Unit | 1771 |
Art Unit(s) | 1771 |
Total Applications | 4 |
Issued Applications | 4 |
Pending Applications | 0 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5834738
[patent_doc_number] => 20060246569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Packaging systems for human recombinant adenovirus to be used in gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/485114
[patent_app_country] => US
[patent_app_date] => 2006-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16404
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246569.pdf
[firstpage_image] =>[orig_patent_app_number] => 11485114
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/485114 | Packaging systems for human recombinant adenovirus to be used in gene therapy | Jul 11, 2006 | Abandoned |
Array
(
[id] => 5621492
[patent_doc_number] => 20060191027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/327847
[patent_app_country] => US
[patent_app_date] => 2006-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32446
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20060191027.pdf
[firstpage_image] =>[orig_patent_app_number] => 11327847
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/327847 | Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof | Jan 5, 2006 | Abandoned |
Array
(
[id] => 5053117
[patent_doc_number] => 20070033662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'GLP-2 receptor gene promoter and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/299663
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 13649
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20070033662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11299663
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/299663 | GLP-2 receptor gene promoter and uses thereof | Dec 12, 2005 | Abandoned |
Array
(
[id] => 5881615
[patent_doc_number] => 20060030698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Nucleic acid molecules and other molecules associated with plants'
[patent_app_type] => utility
[patent_app_number] => 11/256614
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23129
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20060030698.pdf
[firstpage_image] =>[orig_patent_app_number] => 11256614
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/256614 | Nucleic acid molecules and other molecules associated with plants | Oct 23, 2005 | Abandoned |
Array
(
[id] => 884572
[patent_doc_number] => 07351697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-01
[patent_title] => 'Tumor-specific vector for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/186055
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4531
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/351/07351697.pdf
[firstpage_image] =>[orig_patent_app_number] => 11186055
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/186055 | Tumor-specific vector for gene therapy | Jul 20, 2005 | Issued |
Array
(
[id] => 6926482
[patent_doc_number] => 20050239738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Genetic inhibition of epidermal growth factor receptor function and carcinoma cell radiosensitization'
[patent_app_type] => utility
[patent_app_number] => 11/147349
[patent_app_country] => US
[patent_app_date] => 2005-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 21245
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239738.pdf
[firstpage_image] =>[orig_patent_app_number] => 11147349
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/147349 | Genetic inhibition of epidermal growth factor receptor function and carcinoma cell radiosensitization | Jun 7, 2005 | Abandoned |
Array
(
[id] => 5882873
[patent_doc_number] => 20060031956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Nucleotide sequences for gene regulation and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/129861
[patent_app_country] => US
[patent_app_date] => 2005-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 28664
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20060031956.pdf
[firstpage_image] =>[orig_patent_app_number] => 11129861
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/129861 | Nucleotide sequences for gene regulation and methods of use thereof | May 15, 2005 | Issued |
11/124617 | Novel mutated mammalian cells and animals | May 5, 2005 | Abandoned |
Array
(
[id] => 5766742
[patent_doc_number] => 20060018888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Suicidal mutant leishmania vaccine'
[patent_app_type] => utility
[patent_app_number] => 11/091882
[patent_app_country] => US
[patent_app_date] => 2005-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 18114
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018888.pdf
[firstpage_image] =>[orig_patent_app_number] => 11091882
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/091882 | Suicidal mutant Leishmania vaccine | Mar 27, 2005 | Issued |
Array
(
[id] => 484639
[patent_doc_number] => 07217411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-15
[patent_title] => 'CeSERT genes, proteins, and modulatory compounds'
[patent_app_type] => utility
[patent_app_number] => 11/033003
[patent_app_country] => US
[patent_app_date] => 2005-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 27
[patent_no_of_words] => 19130
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/217/07217411.pdf
[firstpage_image] =>[orig_patent_app_number] => 11033003
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/033003 | CeSERT genes, proteins, and modulatory compounds | Jan 10, 2005 | Issued |
Array
(
[id] => 6938540
[patent_doc_number] => 20050112103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Methods and compositions for the treatment of defects in lipoprotein metabolism'
[patent_app_type] => utility
[patent_app_number] => 11/029942
[patent_app_country] => US
[patent_app_date] => 2005-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 16488
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112103.pdf
[firstpage_image] =>[orig_patent_app_number] => 11029942
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/029942 | Methods and compositions for the treatment of defects in lipoprotein metabolism | Jan 4, 2005 | Issued |
Array
(
[id] => 5882864
[patent_doc_number] => 20060031947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Novel mutated mammalian cells and animals'
[patent_app_type] => utility
[patent_app_number] => 11/021492
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 5496
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20060031947.pdf
[firstpage_image] =>[orig_patent_app_number] => 11021492
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/021492 | Novel mutated mammalian cells and animals | Dec 22, 2004 | Abandoned |
Array
(
[id] => 820471
[patent_doc_number] => 07407801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-05
[patent_title] => 'Truncated CMV promoters and vectors containing same'
[patent_app_type] => utility
[patent_app_number] => 11/005410
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 11
[patent_no_of_words] => 7526
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/407/07407801.pdf
[firstpage_image] =>[orig_patent_app_number] => 11005410
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/005410 | Truncated CMV promoters and vectors containing same | Dec 5, 2004 | Issued |
Array
(
[id] => 6944723
[patent_doc_number] => 20050196772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation'
[patent_app_type] => utility
[patent_app_number] => 10/978758
[patent_app_country] => US
[patent_app_date] => 2004-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17212
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196772.pdf
[firstpage_image] =>[orig_patent_app_number] => 10978758
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/978758 | Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation | Oct 31, 2004 | Abandoned |
Array
(
[id] => 6983245
[patent_doc_number] => 20050153315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Dimethylarginine dimethylaminohydrolases'
[patent_app_type] => utility
[patent_app_number] => 10/966039
[patent_app_country] => US
[patent_app_date] => 2004-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13563
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153315.pdf
[firstpage_image] =>[orig_patent_app_number] => 10966039
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/966039 | Dimethylarginine dimethylaminohydrolases | Oct 17, 2004 | Abandoned |
Array
(
[id] => 435632
[patent_doc_number] => 07261886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-28
[patent_title] => 'Insect larva aerosol infection method for producing recombinant proteins and baculovirus bio-insecticides'
[patent_app_type] => utility
[patent_app_number] => 10/945898
[patent_app_country] => US
[patent_app_date] => 2004-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2598
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/261/07261886.pdf
[firstpage_image] =>[orig_patent_app_number] => 10945898
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/945898 | Insect larva aerosol infection method for producing recombinant proteins and baculovirus bio-insecticides | Sep 21, 2004 | Issued |
Array
(
[id] => 893956
[patent_doc_number] => 07341710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-11
[patent_title] => 'Method of identifying molecules that home to a selected organ in vivo'
[patent_app_type] => utility
[patent_app_number] => 10/943372
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11312
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/341/07341710.pdf
[firstpage_image] =>[orig_patent_app_number] => 10943372
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/943372 | Method of identifying molecules that home to a selected organ in vivo | Sep 16, 2004 | Issued |
Array
(
[id] => 7252420
[patent_doc_number] => 20040259208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Liver specific transcriptional enhancer'
[patent_app_type] => new
[patent_app_number] => 10/885457
[patent_app_country] => US
[patent_app_date] => 2004-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14085
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259208.pdf
[firstpage_image] =>[orig_patent_app_number] => 10885457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/885457 | Liver specific transcriptional enhancer | Jul 5, 2004 | Issued |
Array
(
[id] => 7177902
[patent_doc_number] => 20050123942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Novel sphingosine kinases'
[patent_app_type] => utility
[patent_app_number] => 10/876281
[patent_app_country] => US
[patent_app_date] => 2004-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 34672
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123942.pdf
[firstpage_image] =>[orig_patent_app_number] => 10876281
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/876281 | Novel sphingosine kinases | Jun 23, 2004 | Abandoned |
Array
(
[id] => 7334067
[patent_doc_number] => 20040255342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Transgenic flies expressing Abeta42-Iowa'
[patent_app_type] => new
[patent_app_number] => 10/852973
[patent_app_country] => US
[patent_app_date] => 2004-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14058
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20040255342.pdf
[firstpage_image] =>[orig_patent_app_number] => 10852973
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/852973 | Transgenic flies expressing Abeta42-Iowa | May 24, 2004 | Abandoned |